Searched for
GRANULES PHARMA
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...- For investors with long-term perspective: 5 mid-cap stocks from different sectors with upside potential of up to 30%Even before the US-Israel-Iran war began, there was a sort of readjustment taking place in the mid-cap segment – a kind of valuation readju...
- Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...
- Fire at subsidiary unit temporarily hits production: Aurobindo PharmaAurobindo Pharma reported a fire incident on September 18, 2025, at its APL Healthcare Unit-IV in Andhra Pradesh due to a short circuit, ca...
- Stock Radar: 50% rally from June lows! A breakout above falling trendline could push it to fresh 52-week high; here’s whyThe stock with a market capitalisation of more than Rs 8,500 crore hit a 52 week-high of Rs 362
- Pharma company Granules India names KVS Ram Rao as Joint MD, CEORao has over two decades of experience in pharmaceutical and chemical industries.
- Granules India gets USFDA nod for potassium chloride tablets used to treat hypokalemiaGranules has received marketing approval from the US Food and Drug Administration (USFDA) for Potassium Chloride extended release tablets U...
- API makers surge up to 110% in 50 days as virus hits Chinese exportsBrokerage sees coronavirus crisis as a positive for companies like Granules India and Natco.
- Granules India to divest entire stake in Granules OmniChem to JV partnerSA Ajinomoto Omnichem NV will take over full control of the contract research and manufacturing services (CRAMS) business, said Granules In...
- Granules' US unit gets two USFDA observationsAs per the USFDA, a Form 483, is issued to a firm's management at the conclusion of an inspection when investigator has observed any condit...
- Granules' arm completes audit with USFDAGranules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company completed its first audit from December 4-8, 2017 by the USF...
- Granules acquires rights for 4 products from USpharma WindlasGranules said it will be responsible for the marketing and distribution of the products in the US, subject to the final approval by the US ...
- Granules India gets Establishment Inspection Report from USFDAGranules India has received Establishment Inspection Report from the US health regulator for the inspection done at the company's Jeedimetl...
- Strong fundamentals, reasonable valuations make analysts bullish on Granules IndiaMore analysts are getting attracted to this counter because the recent correction has brought down its valuations to reasonably levels.
- Ajanta Pharma launches generic asthma drug in US marketAjanta Pharma today said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market.
- Ajanta Pharma gets USFDA nod for generic asthma treatment drugDrug firm Ajanta Pharma has received final approvals from the US health regulator for generic montelukast tablets and oral granules.
- See stocks like Sundram Fasteners & Igarashi Motors giving 40%-60% returns in next one year: Devang Mehta"Some stocks that immediately come to my mind are Sundram Fasteners and Igarashi Motors ... These two stocks, along with others, can return...
- Granules buys Auctus Pharma in Rs 100 crore dealHyderabad-based pharmaceutical firm Granules India has agreed to buy Auctus Pharma for about Rs 100 crore in an all-cash deal.
- Granules India agrees to acquire Auctus PharmaThe acquisition process is expected to be completed in the next 3 to 6 months, a release from Hyderabad-based Granules India said.
- Granules looks to buy controlling stake in Chinese coHyderabad-based pharma firm Granules India is close to finalising a Rs 180-200-crore deal with a Chinese pharmaceutical company.
Load More
